ASTEX PHARMACEUTICALS, INC Revenue
ASTEX PHARMACEUTICALS, INC reported Revenue of $16.61 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Income Statement
us-gaap:SalesRevenueNet · last filed 2013-08-09
- ASTEX PHARMACEUTICALS, INC revenue, net (deprecated 2018-01-31) for the quarter ending 2013-06-30 was $16.61M, a 16.42% decline year-over-year.
- ASTEX PHARMACEUTICALS, INC revenue, net (deprecated 2018-01-31) for the quarter ending 2013-03-31 was $22.09M, a 0.30% increase year-over-year.
- ASTEX PHARMACEUTICALS, INC revenue, net (deprecated 2018-01-31) for the quarter ending 2012-12-31 was $24.06M, a 13.47% increase year-over-year.
- ASTEX PHARMACEUTICALS, INC revenue, net (deprecated 2018-01-31) for the quarter ending 2012-09-30 was $17.19M, a 1.46% increase year-over-year.
- ASTEX PHARMACEUTICALS, INC revenue, net (deprecated 2018-01-31) for fiscal 2012 was $83.16M, a 24.28% increase from fiscal 2011.
- ASTEX PHARMACEUTICALS, INC revenue, net (deprecated 2018-01-31) for fiscal 2011 was $66.91M, a 26.32% increase from fiscal 2010.
- ASTEX PHARMACEUTICALS, INC revenue, net (deprecated 2018-01-31) for fiscal 2010 was $52.97M, a 28.41% increase from fiscal 2009.
- ASTEX PHARMACEUTICALS, INC revenue, net (deprecated 2018-01-31) for fiscal 2009 was $41.25M.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2013-06-30 | $16.61M 10-Q · filed 2013-08-09 | $38.70M 10-Q · filed 2013-08-09 | $62.77M derived: sum of 3 quarters · filed 2013-08-09 | $79.96M derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | $22.09M 10-Q · filed 2013-05-10 | $46.15M derived: sum of 2 quarters · filed 2013-05-10 | $63.34M derived: sum of 3 quarters · filed 2013-05-10 | $83.22M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-12-31 | $24.06M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $41.26M derived: sum of 2 quarters · filed 2013-03-18 | $61.13M derived: sum of 3 quarters · filed 2013-08-09 | $83.16M 10-K · filed 2013-03-18 |
| 2012-09-30 | $17.19M 10-Q · filed 2012-11-09 | $37.07M derived: sum of 2 quarters · filed 2013-08-09 | $59.10M 10-Q · filed 2012-11-09 | $80.30M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-06-30 | $19.88M 10-Q · filed 2013-08-09 | $41.90M 10-Q · filed 2013-08-09 | $63.11M derived: sum of 3 quarters · filed 2013-08-09 | $80.05M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-03-31 | $22.02M 10-Q · filed 2013-05-10 | $43.23M derived: sum of 2 quarters · filed 2013-05-10 | $60.17M derived: sum of 3 quarters · filed 2013-05-10 | $71.84M derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | $21.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $38.15M derived: sum of 2 quarters · filed 2013-03-18 | $49.82M derived: sum of 3 quarters · filed 2013-03-18 | $66.91M 10-K · filed 2013-03-18 |
| 2011-09-30 | $16.95M 10-Q · filed 2012-11-09 | $28.61M derived: sum of 2 quarters · filed 2012-11-09 | $45.71M 10-Q · filed 2012-11-09 | $60.99M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $11.67M 10-Q · filed 2012-08-09 | $28.76M 10-Q · filed 2012-08-09 | $44.05M derived: sum of 3 quarters · filed 2013-03-18 | $57.42M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $17.10M 10-Q · filed 2012-05-10 | $32.38M derived: sum of 2 quarters · filed 2013-03-18 | $45.76M derived: sum of 3 quarters · filed 2013-03-18 | $55.65M derived: sum of 4 quarters · filed 2013-03-18 |
| 2010-12-31 | $15.28M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $28.66M derived: sum of 2 quarters · filed 2013-03-18 | $38.55M derived: sum of 3 quarters · filed 2013-03-18 | $52.97M 10-K · filed 2013-03-18 |
| 2010-09-30 | $13.38M 10-Q · filed 2011-11-09 | $23.27M derived: sum of 2 quarters · filed 2011-11-09 | $37.69M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $9.89M 10-Q · filed 2011-08-09 | $24.31M 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | $41.25M 10-K · filed 2012-03-15 |